Bridgewater Associates LP Trims Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Bridgewater Associates LP lowered its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 74.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,075 shares of the company's stock after selling 5,944 shares during the quarter. Bridgewater Associates LP's holdings in Addus HomeCare were worth $260,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Smartleaf Asset Management LLC grew its stake in shares of Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after purchasing an additional 214 shares during the period. Parkside Financial Bank & Trust increased its holdings in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after buying an additional 148 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Addus HomeCare during the 4th quarter valued at about $77,000. Harvest Fund Management Co. Ltd purchased a new position in shares of Addus HomeCare in the 4th quarter valued at about $86,000. Finally, KBC Group NV raised its holdings in Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

NASDAQ ADUS traded up $0.99 during trading hours on Friday, hitting $100.53. 59,310 shares of the company's stock traded hands, compared to its average volume of 162,870. The company has a market capitalization of $1.83 billion, a PE ratio of 23.01, a PEG ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72. The firm's 50-day moving average is $98.20 and its 200-day moving average is $116.35.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $297.14 million during the quarter, compared to analysts' expectations of $291.04 million. Equities research analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ADUS. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Macquarie restated an "outperform" rating and set a $129.00 price objective on shares of Addus HomeCare in a research report on Thursday, February 27th. Stephens reiterated an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Wednesday, March 12th. Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday. One research analyst has rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $139.00.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.